ELIAS JOSEPH JABBOUR to Tumor Burden
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Tumor Burden.
Connection Strength
0.062
-
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden. Am J Hematol. 2021 08 01; 96(8):E275-E279.
Score: 0.032
-
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies. Ann Hematol. 2020 Oct; 99(10):2215-2229.
Score: 0.030